Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 3
2000 2
2002 1
2003 1
2004 7
2005 9
2006 3
2007 9
2008 4
2009 7
2010 4
2011 5
2012 7
2013 4
2014 6
2015 7
2016 7
2017 6
2018 4
2019 7
2020 10
2021 23
2022 20
2023 15
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Primary HIV-1 infection in users of pre-exposure prophylaxis.
Ambrosioni J, Petit E, Liegeon G, Laguno M, Miró JM. Ambrosioni J, et al. Among authors: laguno m. Lancet HIV. 2021 Mar;8(3):e166-e174. doi: 10.1016/S2352-3018(20)30271-X. Epub 2020 Dec 11. Lancet HIV. 2021. PMID: 33316212 Review.
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
Rocabert A, Borjabad B, Berrocal L, Blanch J, Inciarte A, Chivite I, Gonzalez-Cordon A, Torres B, Ambrosioni J, Martinez-Rebollar M, Laguno M, De La Mora L, Foncillas A, Sempere A, Rodriguez A, Solbes E, Llobet R, Miro JM, Mallolas J, Blanco JL, De Lazzari E, Martinez E. Rocabert A, et al. Among authors: laguno m. J Antimicrob Chemother. 2023 Dec 1;78(12):2961-2967. doi: 10.1093/jac/dkad338. J Antimicrob Chemother. 2023. PMID: 37875023
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
Borjabad B, Inciarte A, Chivite I, Gonzalez-Cordon A, Mosquera M, Hurtado C, Rovira C, Gonzalez T, Sempere A, Torres B, Calvo J, De La Mora L, Martinez-Rebollar M, Laguno M, Foncillas A, Ambrosioni J, Blanch J, Rodriguez A, Solbes E, Llobet R, Berrocal L, Mallolas J, Miro JM, Alcami J, Blanco JL, Sanchez-Palomino S, De Lazzari E, Martinez E. Borjabad B, et al. Among authors: laguno m. J Antimicrob Chemother. 2024 Feb 1;79(2):255-261. doi: 10.1093/jac/dkad364. J Antimicrob Chemother. 2024. PMID: 38039097 Clinical Trial.
Overview of SARS-CoV-2 infection in adults living with HIV.
Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA, Martínez E, Bertagnolio S, Alcamí J, Miro JM; COVID-19 in HIV Investigators. Ambrosioni J, et al. Lancet HIV. 2021 May;8(5):e294-e305. doi: 10.1016/S2352-3018(21)00070-9. Lancet HIV. 2021. PMID: 33915101 Free PMC article. Review.
[Current status of acute hepatitis C].
Martínez-Rebollar M, Larrousse M, Calvo M, Muñoz A, González A, Loncà M, Martínez E, Blanco JL, Mallolas J, Laguno M. Martínez-Rebollar M, et al. Among authors: laguno m. Enferm Infecc Microbiol Clin. 2011 Mar;29(3):210-5. doi: 10.1016/j.eimc.2010.12.005. Epub 2011 Feb 18. Enferm Infecc Microbiol Clin. 2011. PMID: 21334112 Review. Spanish.
Contributing awareness of autoimmune hepatitis in HIV patients.
Martínez-Rebollar M, Pascual PP, de la Mora L, Londoño MC, Llovet LP, Forns X, Mallolas J, Laguno M. Martínez-Rebollar M, et al. Among authors: laguno m. AIDS. 2019 Nov 1;33(13):2103-2105. doi: 10.1097/QAD.0000000000002299. AIDS. 2019. PMID: 31577575 Review. No abstract available.
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV.
Laguno M, de Lazzari E, Berrocal L, Inciarte A, Martínez-Rebollar M, de la Mora L, Torres B, Gonzalez-Cordón A, Chivite I, Foncillas A, Calvo J, Sempere A, Ambrosioni J, Blanco JL, Miro JM, Mallolas J, Martínez E. Laguno M, et al. HIV Med. 2024 Nov 7. doi: 10.1111/hiv.13730. Online ahead of print. HIV Med. 2024. PMID: 39508213
[Characteristics of hepatitis and influenza antivirals: update 2009].
Lopez-Suñé E, Tuset M, Laguno M, Moreno A, Miró JM. Lopez-Suñé E, et al. Among authors: laguno m. Enferm Infecc Microbiol Clin. 2010 Apr;28(4):253.e1-17. doi: 10.1016/j.eimc.2010.02.001. Epub 2010 Apr 14. Enferm Infecc Microbiol Clin. 2010. PMID: 20395018 Review. Spanish.
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Inciarte A, Ugarte A, Martínez-Rebollar M, Torres B, Fernández E, Berrocal L, Laguno M, De la Mora L, De Lazzari E, Callau P, Chivite I, González-Cordón A, Solbes E, Rico V, Barrero L, Blanco JL, Martínez E, Ambrosioni J, Mallolas J; DORAVIPEP Study Group. Inciarte A, et al. Among authors: laguno m. Open Forum Infect Dis. 2023 Jul 19;10(8):ofad374. doi: 10.1093/ofid/ofad374. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37539061 Free PMC article.
158 results